GPT Healthcare IPO - Review & Fundamental Analysis

GPT Healthcare IPO

GPT Healthcare IPO consists of a fresh issue of shares worth INR 40 crores and an offer to sell 2.60 crore existing equity shares. The company seeks funds for loan repayment, prepayment, and general corporate funding purposes.

GPT Healthcare Limited IPO – Important Details 

GPT Healthcare IPO DateFebruary 22, 2024 to February 26, 2024
GPT Healthcare IPO Listing DateFebruary 29, 2024
GPT Healthcare IPO PriceINR 177 to 186 per share
GPT Healthcare IPO Lot Size80 Shares
GPT Healthcare IPO Total Issue Size525.14 Cr
GPT Healthcare IPO Basis of AllotmentFebruary 27, 2024
GPT Healthcare IPO Initiation of RefundsFebruary 28, 2024
GPT Healthcare IPO Credit of Shares to DematFebruary 28, 2024
GPT Healthcare IPO Issue TypeBook Built Issue 
GPT Healthcare IPO Listing AtBSE, NSE

GPT Healthcare Ltd IPO – Company Profile

GPT Healthcare, a prominent player in Eastern India’s healthcare sector, boasts a chain of mid-sized full-service hospitals, prioritizing secondary and tertiary care. Leading in beds and hospitals, it emphasizes integrated healthcare services. 

They operate four multispecialty hospitals across West Bengal and Tripura, with 561 beds. Offering over 35 specialties, including internal medicine, surgery, and critical care, each hospital provides integrated diagnostics and pharmacies.

They strategically target Eastern India’s under-penetrated healthcare market, present in three cities. This fosters an understanding of regional nuances, patient culture, and medical professionals’ mindset, addressing the need for quality and affordable services. 

GPT Healthcare Limited IPO – Fundamental Analysis 

GPT Healthcare Ltd’s IPO financials reveal consistent revenue growth, notable profitability, and improved debt management, positioning it as a compelling investment within the healthcare sector with strong operational efficiency and a promising outlook for future growth.

Revenue Growth:

The company has demonstrated consistent revenue growth from ₹2,427.53 million in 2021 to ₹3,610.37 million in 2023. This steady increase suggests a solid demand for its healthcare services and an expanding market presence.

Equity Expansion:

Equity has gradually increased from ₹1,339.01 million in 2021 to ₹1,653.62 million in 2023, reflecting the company’s ability to accumulate assets a